期刊
CANCERS
卷 10, 期 10, 页码 -出版社
MDPI
DOI: 10.3390/cancers10100377
关键词
circulating tumor cells; CellSearch (R); EpCAM; leukocytes; ACCEPT; deep Learning; classification; image analysis; non-small cell lung cancer
类别
资金
- EU FP7 CTC-Trap grant [305341]
- EU IMI CANCER-ID grant [115749-1]
- Janssen Diagnostics
In the CellSearch (R) system, blood is immunomagnetically enriched for epithelial cell adhesion molecule (EpCAM) expression and cells are stained with the nucleic acid dye 4'6-diamidino-2-phenylindole (DAPI), Cytokeratin-PE (CK), and CD45-APC. Only DAPI+/CK+ objects are presented to the operator to identify circulating tumor cells (CTC) and the identity of all other cells and potential undetected CTC remains unrevealed. Here, we used the open source imaging program Automatic CTC Classification, Enumeration and PhenoTyping (ACCEPT) to analyze all DAPI+ nuclei in EpCAM-enriched blood samples obtained from 192 metastatic non-small cell lung cancer (NSCLC) patients and 162 controls. Significantly larger numbers of nuclei were detected in 300 patient samples with an average and standard deviation of 73,570 +/- 74,948, as compared to 359 control samples with an average and standard deviation of 4191 +/- 4463 (p < 0.001). In patients, only 18% +/- 21% and in controls 23% 15% of the nuclei were identified as leukocytes or CTC. Adding CD16-PerCP for granulocyte staining, the use of an LED as the light source for CD45-APC excitation and plasma membrane staining obtained with wheat germ agglutinin significantly improved the classification of EpCAM-enriched cells, resulting in the identification of 94% +/- 5% of the cells. However, especially in patients, the origin of the unidentified cells remains unknown. Further studies are needed to determine if undetected EpCAM+/DAPI+/CK-/CD45-CTC is present among these cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据